李隽暘 Email & Phone Number

Shanghai, China

efgartigimod Brand team, NRDL coordination, brand strategy design,etc

中国 上海市

Responsible for Fasenra, biologics on severe asthma, prelaunch work, focus on CoE establishment before launch

中国 上海市 浦东新区

Responsible for Evusheld prelaunch work in respiratory, infectious department◼ Collaborated with medical team and regional sales for KEEs mapping and ranking, and defined the respiratory & infectious dept. KEEs as the concept shapers◼ Successfully converting 20 National respiratory & infectious dept. KEEs into supporters through series of PR interviews &.

中国 上海 浦东新区

➢ In charge of PCCM project routine management & upgrade◼ Connected closely with the urgent business needs, successfully listed the COPD patients lung function test rate, inhaler prescription rate and follow-up rate quality control requirements into the new PCCM standard in Dec. 2021◼ Facilitating the realization of the new standards and amplifying the.

中国 上海 浦东新区

Working as the member of Breztri & Bevespi brand team◼ Succeeded in helping Breztri listed in 300+ hospitals before NRDL ~700 hospitals listed by Jun. 2021 after NRDL took effect in Mar. 2021◼ Prepared the NRDL related material with CAMA team, successfully helped the Breztri & Bevespi listed in NRDL◼ Maintaining Breztri >85% MS% in closed-triple inhaler.

上海

➢ In charge of Cancidas Hema Dept. promotion, accounting for up to 50% product sales revenue, reached A/T 95% in 2019, the No.1 MS% (24%) in IFD IV market◼ Collaborating with Hema NKOLs on Hema Elite Forum campaign, establishing academic platform offline & online, thus strengthening Cancidas 1st choice in IFD treatment in Hema, the HSC sales most favorite.

上海 浦东新区

Working as a member of PCCM project execution team, including internal training, HCPs on-site training, certification process and award sessions, winning 2018 AZ President Prize and Moscar Prize as the most influential innovative project in 2018

中国 上海市区

In charge of fusidic acid cream, accounting for over 22% sales of dermatology BU, with the 3rd largest MS% in National IMS Data, maintaining 15% of growth each year (dermatology 0.9%, field 9%)

中国 上海市区

Managing clinical academic promotion and formulating national market strategy for Bifico Powder, during 2014 - 2016, Bifico Powder has maintained about 25% of growth each year (Field 15%)

Master Of Science - Ms, Biomedicine, 83.67/100

Activities and Societies: 2010.09-2012.12 营养所学生会 文体部部长

Bachelor Of Science - Bs, Biology, Gpa： 3.17/4.00

Activities and Societies: 2006.09-2007.07 复旦大学学生会 文艺部副部长 2007.09-2010.06 生科院团学联 文体部部长